Absci Corp
ABSINasdaq
$8.30
↑ +0.8%Jul 17 close · end-of-day
Price
1Y↑ +202.7%
End-of-day closes; the latest point is the live 15-min-delayed price · split & dividend adjusted · chart by TradingView
Key statistics
Market Cap
$1.3B
Enterprise Value
$1.1B
P/E
—
P/S
691.1
P/B
7.4
EV/EBITDA
—
PEG
—
FCF Yield
-7.8%
Dividend Yield
—
Revenue (TTM)
$1.8M
Net Income (TTM)
-$118.4M
Free Cash Flow (TTM)
-$98.5M
Gross Margin
—
Operating Margin
-6723.0%
Net Margin
—
ROE
—
ROIC
-210.8%
Debt / Equity
—
Net Cash
$125.7M
Return 1Y
+188.0%
Company profile
Absci Corporation provides biologic drug candidates and production cell lines using integrated drug creation platform for partners in the United States. Absci was founded in 2011 and is headquartered in Vancouver, Washington.
- CEO
- Sean McClain
- Sector
- Services
- Industry
- Business Services
- Employees
- 210
- Headquarters
- Washington
- Website
- absci.com
Management & directors
- Mcclain SeanChief Executive Officer
- Jonasson ZachariahCFO / CBO
- Busch AndreasChief Innovation Officer
- Bedrick ToddSVP, CAO
- Walker Shelby J.Chief Legal Officer
Roles derived from SEC Form 4 filings.
Earnings
ABSI Q1 2026 Earnings
Period ends 2026-03-31
MetricActualYoY
Revenue$215,000.00↓ -81.8%
Diluted EPS-$0.19↓ -9.5%
Actuals from SEC filings; YoY vs the year-ago quarter. Analyst estimates & surprise require a data feed (coming soon).
Financial statements
| Line item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Revenue | $4.8M | $4.8M | $5.7M | $5.7M | $4.5M | $2.8M |
| Gross profit | — | — | — | — | — | — |
| Operating income | -$13.3M | -$75.2M | -$106.8M | -$115.5M | -$108.9M | -$120.3M |
| Net income | -$14.4M | -$101.0M | -$104.9M | -$110.6M | -$103.1M | -$115.2M |
| Diluted EPS | -$3.19 | -$2.08 | -$1.15 | -$1.20 | -$0.94 | -$0.84 |
| Operating cash flow | -$11.0M | -$60.6M | -$81.3M | -$64.6M | -$72.4M | -$92.9M |
| Free cash flow | -$13.2M | -$98.6M | -$97.5M | -$65.5M | -$72.8M | -$94.0M |
| Gross margin | — | — | — | — | — | — |
| Operating margin | -278.3% | -1573.4% | -1857.5% | -2020.2% | -2401.6% | -4297.0% |
| Net margin | -300.3% | -2111.3% | -1825.4% | -1933.6% | -2274.1% | -4113.7% |
| Line item | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $1.3M | $1.7M | $665,000.00 | $1.2M | $593,000.00 | $378,000.00 | $650,000.00 | $215,000.00 |
| Gross profit | — | — | — | — | — | — | — | — |
| Operating income | -$26.7M | -$28.9M | -$29.8M | -$27.7M | -$31.4M | -$30.2M | -$31.0M | -$30.8M |
| Net income | -$24.8M | -$27.4M | -$29.0M | -$26.3M | -$30.6M | -$28.7M | -$29.6M | -$29.6M |
| Diluted EPS | -$0.22 | -$0.24 | -$0.26 | -$0.21 | -$0.24 | -$0.20 | -$0.19 | -$0.19 |
| Operating cash flow | -$16.8M | -$20.7M | -$17.0M | -$21.8M | -$16.9M | -$25.0M | -$29.2M | -$26.3M |
| Free cash flow | -$17.2M | -$20.8M | -$17.0M | -$21.9M | -$17.1M | -$26.0M | -$29.3M | -$26.3M |
| Gross margin | — | — | — | — | — | — | — | — |
| Operating margin | -2104.0% | -1698.7% | -4477.3% | -2351.9% | -5293.9% | -7977.2% | -4775.5% | -14347.0% |
| Net margin | -1948.8% | -1610.7% | -4358.3% | -2234.6% | -5155.0% | -7594.2% | -4548.0% | -13767.0% |
Company news
Jul 17, 2026
Analyst estimates
Coming soonConsensus revenue & EPS estimates and price targets will appear here once a forward-estimates data feed is connected.
Insider transactions
BoughtSoldMonthly insider $ volume · trailing 12 months
| Date | Insider | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| 2026-06-30 | Szela Mary T | Buy | 12,900 | $11.54 | $148,866.00 | filing |
| 2026-06-24 | McClain Sean· Chief Executive Officer | Tax withholding | 59,896 | $10.08 | $603,452.20 | filing |
| 2026-06-04 | Szela Mary T | Award | 8,400 | $0.00 | $0.00 | filing |
| 2026-06-04 | MCGINNIS KAREN K | Award | 10,100 | $0.00 | $0.00 | filing |
| 2026-06-04 | Szela Mary T | Award | 10,100 | $0.00 | $0.00 | filing |
| 2026-06-04 | Pangalos Menelas N | Award | 10,100 | $0.00 | $0.00 | filing |
| 2026-06-04 | Houten Frans Van | Award | 10,100 | $0.00 | $0.00 | filing |
| 2026-06-04 | Rabinovitsj Daniel A | Award | 10,100 | $0.00 | $0.00 | filing |
| 2026-06-04 | Sirosh Joseph | Award | 10,100 | $0.00 | $0.00 | filing |
| 2026-05-31 | Jonasson Zachariah· CFO / CBO | Tax withholding | 8,319 | $6.75 | $56,153.25 | filing |
| 2026-05-13 | Pangalos Menelas N | Buy | 37,453 | $5.36 | $200,748.08 | filing |
| 2026-03-12 | Busch Andreas· Chief Innovation Officer | Buy | 100,000 | $2.29 | $229,000.00 | filing |
| 2026-03-03 | McClain Sean· Chief Executive Officer | Tax withholding | 25,316 | $2.80 | $70,884.80 | filing |
| 2026-03-03 | Jonasson Zachariah· CFO / CBO | Tax withholding | 10,848 | $2.80 | $30,374.40 | filing |
| 2026-03-03 | Walker Shelby J.· Chief Legal Officer | Tax withholding | 9,825 | $2.80 | $27,510.00 | filing |
| 2026-03-03 | Walker Shelby J.· Chief Legal Officer | Tax withholding | 9,825 | $2.80 | $27,510.00 | filing |
| 2026-03-03 | Bedrick Todd· SVP, CAO | Tax withholding | 5,282 | $2.80 | $14,789.60 | filing |
| 2026-03-02 | Jonasson Zachariah· CFO / CBO | Tax withholding | 8,307 | $2.74 | $22,761.18 | filing |
| 2026-03-02 | Pangalos Menelas N | Award | 5,800 | $0.00 | $0.00 | filing |
| 2026-03-02 | Walker Shelby J.· Chief Legal Officer | Award | 90,300 | $0.00 | $0.00 | filing |
| 2026-03-02 | McClain Sean· Chief Executive Officer | Award | 406,200 | $0.00 | $0.00 | filing |
| 2026-03-02 | Walker Shelby J.· Chief Legal Officer | Award | 90,300 | $0.00 | $0.00 | filing |
| 2026-03-02 | Jonasson Zachariah· CFO / CBO | Award | 135,400 | $0.00 | $0.00 | filing |
| 2026-03-02 | Bedrick Todd· SVP, CAO | Award | 49,600 | $0.00 | $0.00 | filing |
| 2026-02-27 | Pangalos Menelas N | Buy | 75,095 | $2.74 | $205,760.30 | filing |
Showing the latest 25 transactions — full history in the linked SEC filings.
Fundamentals & filings from SEC EDGAR. Prices adjusted for splits & dividends. Not investment advice.